Oxprenolol

氧烯洛尔

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOxprenolol
Drug Alias Nameoxprenololum心得平烯丙氧心安
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-3 adrenergic receptor antagonistsBeta-1 adrenergic receptor antagonistsBeta-2 adrenergic receptor antagonists
TargetsBeta-2 adrenergic receptorBeta-3 adrenergic receptorBeta-1 adrenergic receptor
Therapy Area/IndicationsHypertensionAngina PectorisArrhythmias, Cardiac
Global Approved IndicationsHypertensionAngina PectorisArrhythmias, Cardiac
Approved Indications in ChinaHypertensionAngina PectorisArrhythmias, Cardiac
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesActimed Therapeutics LtdBeijing Wanhui Double-Crane Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionAngina PectorisArrhythmias, Cardiac
Inactive IndicationsN/A

Other Information

ATC CodeC07AA02
Related LinksWikipediaDrugBank